Featured Research

from universities, journals, and other organizations

Saw palmetto no better than placebo in relieving prostate symptoms, even at high doses

Date:
September 27, 2011
Source:
Massachusetts General Hospital
Summary:
Long-term adminstration of the dietary supplement saw palmetto, even at three times the usual dose, did not reduce symptoms of prostate enlargement significantly better than placebo in a large group of middle-aged men.

Long-term adminstration of the dietary supplement saw palmetto, even at three times the usual dose, did not reduce symptoms of prostate enlargement significantly better than placebo in a large group of middle-aged men. The study from researchers at 14 institutions across the U.S. and Canada appears in the September 28 Journal of the American Medical Association and extends the results of several other double-blinded, placebo controlled trials.

Related Articles


"Saw palmetto extracts are commonly used by men with bothersome lower urinary tract symptoms, but our results indicate that the particular extract we tested was no better than a placebo at relieving those symptoms," says Michael Barry, MD, of the Massachusetts General Hospital Department of Medicine, lead author of the JAMA report. "It is possible that other formulations could be helpful, but a number of recent studies with negative results suggest it may be difficult to find a saw palmetto extract that is better than placebo."

Benign prostatic hyperplasia (BPH), commonly referred to as an enlarged prostate, affects around half of men at age 50 and three-quarters by age 80. The condition can be mild, but for many men symptoms such as frequent urination -- including the need to visit the bathroom several times at night -- difficulty urinating, and weak or intermittant urinary flow interfere with their quality of life. Several conventional medications are available to treat BPH, but their side effects can be unpleasant.

Saw palmetto extract is a common alternative treatment for BPH. Some early studies indicated that saw palmetto could reduce symptoms of BPH, but recent, more rigorous trials had less promising results. The largest previous trial, enrolling 225 men over 50, found that a standard dose of 160 mg twice a day for one year was no better than placebo at relieving symptoms. The current study was designed to see whether longer treatment with higher doses would give better results.

Conducted at 11 North American hospitals, the current trial enrolled men over 45 with moderate symptoms of BPH. Participants took daily doses of identical gelcaps that contained either saw palmetto extract or a placebo. The dosage was doubled 28 weeks into the study and then tripled at 48 weeks. Those receiving saw palmetto started at a standard daily dose of 320 mg., increased to 640 mg. and ended at 960 mg. Of the more than 300 participants who completed the study, all reached the triple dose with no significant side effects. At the end of the 72-week study period, participants receiving saw palmetto showed less improvement in a standard index of BPH symptoms than did those taking the placebo.

"The conventional medications we prescribe for BPH can have unpleasant side effects, and participants taking even the highest doses of saw palmetto had no serious adverse effects," Barry says. "So while I would tell a patient interested in trying saw palmetto that I wouldn't object, I'd make sure he understood that, on average, it doesn't seem to work any better than a placebo." Barry is a clinical professor of Medicine at Harvard Medical School

Support for the study -- which was conducted by the Complementary and Alternative Medicine for Urologic Symptoms Study Group -- included grants from the National Institutes of Health, including the National Center for Complementary and Alternative Medicine, and the Office of Dietary Supplements.


Story Source:

The above story is based on materials provided by Massachusetts General Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. Michael J. Barry, Sreelatha Meleth, Jeannette Y. Lee, Karl J. Kreder, Andrew L. Avins, J. Curtis Nickel, Claus G. Roehrborn, E. David Crawford, Harris E. Foster, Jr, Steven A. Kaplan, Andrew Mccullough, Gerald L. Andriole, Michael J. Naslund, O. Dale Williams, John W. Kusek, Catherine M. Meyers, Joseph M. Betz, Alan Cantor, Kevin T. Mcvary, for the Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Study Group. Effect of Increasing Doses of Saw Palmetto Extract on Lower Urinary Tract Symptoms: A Randomized Trial. Journal of the American Medical Association, 2011; 306 (12): 1344-1351 DOI: 10.1001/jama.2011.1364

Cite This Page:

Massachusetts General Hospital. "Saw palmetto no better than placebo in relieving prostate symptoms, even at high doses." ScienceDaily. ScienceDaily, 27 September 2011. <www.sciencedaily.com/releases/2011/09/110927161640.htm>.
Massachusetts General Hospital. (2011, September 27). Saw palmetto no better than placebo in relieving prostate symptoms, even at high doses. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2011/09/110927161640.htm
Massachusetts General Hospital. "Saw palmetto no better than placebo in relieving prostate symptoms, even at high doses." ScienceDaily. www.sciencedaily.com/releases/2011/09/110927161640.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Liberia Releases Last Ebola Patient, But Threat Remains

Liberia Releases Last Ebola Patient, But Threat Remains

Newsy (Mar. 5, 2015) Liberia&apos;s last Ebola patient has been released, and the country hasn&apos;t recorded a new case in a week. However, fears of another outbreak still exist. Video provided by Newsy
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

More Coverage


Increasing Dosage of Saw Palmetto Does Not Appear to Reduce Urinary Symptoms from Enlarged Prostate

Sep. 27, 2011 Men with urinary problems related to an enlarged prostate who received increasing doses of the fruit extract saw palmetto did not experience a reduction in these symptoms compared to men who received ... read more

Saw Palmetto No Benefit as Prostate Remedy

Sep. 27, 2011 The fruit of the saw palmetto tree does not relieve symptoms of an enlarged prostate, even when men take the herbal supplement in very high doses, a new study ... read more

Popular Supplement Has No Effect on Prostate Health, Clinical Study Shows

Sep. 27, 2011 The most widely used over-the-counter supplement for prostate health is no more effective than a placebo in treating men's lower urinary tract symptoms, according to new ... read more

Saw Palmetto No More Effective Than Placebo for Urinary Symptoms; Study Finds Dietary Supplement Does Not Alleviate BPH

Sep. 27, 2011 Saw palmetto, a widely used herbal dietary supplement, does not reduce urinary problems associated with prostate enlargement any better than a placebo, according to new ... read more

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins